Apollo Hospitals stock has surged over 14% in the last three months. Experts suggest short-term traders to accumulate the stock on dips towards Rs 4,950 for a possible target of Rs 5,700 in two months. After a breakout in May on the daily charts, the stock surpassed INR5,000 levels in June. The Supertrend indicator triggered a buy on April 28.
JPMorgan has started coverage of Apollo Hospitals as overweight, with a target price of INR 5,950 ($80). The bank has started coverage of Fortis Healthcare as overweight, with a INR 355 target. Morgan Stanley downgraded Tata Chemicals to equal-weight, downgraded its target price to INR 916 and maintained an overweight rating on Indigo with a target price of INR 3,126. Furthermore, InCred began covering HEG with an add rating and expects it to trend upwards due to reduced US steel inventory levels. Jefferies maintained a buy rating on Dalmia Bharat with a target price of INR 2,490.
From last six months, Apollo Hospitals has been consolidating in broader range of Rs 4,900-4.150 levels as big wild swings kept the stock volatile over the period of months.
Apollo Hospitals, on the weekly charts, has decisively broken out above the 'cup and handle' pattern at Rs 4,900 level, accompanied by an increase in volume.
Stocks recommended by share market analysts: Stock brokerages have come out with research reports on select stocks namely Apollo Hospitals, Bandhan Bank, Prestige Estates, and Rolex Rings. Here s what brokerages said about these counters. Also check target price, and more.